Definium Therapeutics, Inc.

DFTX Nasdaq CIK: 0001813814

Company Information

Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation British Columbia, Canada
Business Address ONE WORLD TRADE CENTER, NEW YORK, NY, 10007
Mailing Address ONE WORLD TRADE CENTER, NEW YORK, NY, 10007
Phone 212-220-6633
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 26, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
10-K Annual financial report February 26, 2026 View on SEC
8-K Current report of material events February 26, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 17, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
4 Insider stock transaction report February 5, 2026 View on SEC

Insider Trading

STRONG SELL 3 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2833)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.